- idUS
- Listar por autor
Listar por autor "Miró-Canturri, Andrea"
Mostrando ítems 1-5 de 5
-
Artículo
Efficacy of lysophosphatidylcholine as direct treatment in combination with colistin against acinetobacter baumannii in murine severe infections models
Miró-Canturri, Andrea; Ayerbe Algaba, Rafael; Jiménez-Mejías, Manuel Enrique; Pachón Díaz, Jerónimo; Smani, Younes (MDPI, 2021-02-17)The stimulation of the immune response to prevent the progression of an infection may be an adjuvant to antimicrobial ...
-
Artículo
Potential tamoxifen repurposing to combat infections by multidrug-resistant Gram-negative bacilli
Miró-Canturri, Andrea; Ayerbe Algaba, Rafael; Toro Estévez, Raquel del; Jiménez-Mejías, Manuel Enrique; Pachón Díaz, Jerónimo; Smani, Younes (2021-05-26)The development of new strategic therapies for multidrug-resistant bacteria, like the use of non-antimicrobial approaches ...
-
Tesis Doctoral
Reposicionamiento de fármacos para el tratamiento de infecciones causadas por bacilos gramnegativos multirresistentes
Miró-Canturri, Andrea (2020-07-14)El aumento de bacterias multirresistentes y la dificultad de encontrar un tratamiento eficaz para este tipo de infecciones, ...
-
Artículo
Repurposing of the tamoxifen metabolites to combat infections by multidrug-resistant gram-negative bacilli
Miró-Canturri, Andrea; Ayerbe Algaba, Rafael; Vila-Domínguez, Andrea; Jiménez-Mejías, Manuel Enrique; Pachón Díaz, Jerónimo (Multidisciplinary Digital Publishing Institute, 2021-03-22)The development of new strategic antimicrobial therapeutic approaches, such as drug repurposing, has become an urgent need. ...
-
Artículo
Repurposing of the Tamoxifen Metabolites to Treat Methicillin-Resistant Staphylococcus epidermidis and Vancomycin-Resistant Enterococcus faecalis Infections
Miró-Canturri, Andrea; Vila-Domínguez, Andrea; Caretero-Ledesma, Marta; Ayerbe Algaba, Rafael; Pachón Díaz, Jerónimo; Jiménez-Mejías, Manuel E.; Smani, Younes (American Society of Microbiology, 2021-10-20)Repurposing drugs provides a new approach to the fight against multidrug-resistant (MDR) bacteria. We have reported that ...